Clinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept

被引：0
|
作者：
Pallavi Tyagi
Zain Juma
Yong Keen Hor
Neil W. Scott
Andreea Ionean
Cynthia Santiago
机构：
[1] Department of Ophthalmology,The school of medicine
[2] Aberdeen Royal infirmary,Medical Statistics Team
[3] University of Aberdeen,undefined
[4] University of Aberdeen,undefined
来源：
BMC Ophthalmology | / 18卷
关键词：
Aflibercept; Pigment epithelial detachment; Neovascular age related macular degeneration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Efficacy of intravitreal aflibercept treatment of pigment epithelial detachment in neovascular age-related macular degeneration refractory to intravitreal ranibizumab: 2-year outcomes
    Ramskold, Louise
    Lee, Han Bin
    Chandran, Manju N.
    Gencheva, Petya
    Menon, Geeta
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [22] Factors associated with poor response to aflibercept after switching from ranibizumab or bevacizumab in neovascular age-related macular degeneration (AMD)
    Cheng, Sarah
    Leng, Theodore
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [23] Rapid response of retinal pigment epithelial detachments to intravitreal aflibercept in neovascular age-related macular degeneration refractory to bevacizumab and ranibizumab
    Patel, K. H.
    Chow, C. C.
    Rathod, R.
    Mieler, W. F.
    Lim, J. I.
    Ulanski, L. J., II
    Leiderman, Y. I.
    Arun, V.
    Chau, F. Y.
    EYE, 2013, 27 (05) : 668 - 668
  • [24] Ranibizumab versus aflibercept for the treatment of vascularized pigment epithelium detachment due to age-related macular degeneration
    Alexandros Rouvas
    Irini Chatziralli
    Angeliki Androu
    Panagiota Mpougatsou
    Dimitrios Alonistiotis
    Maria Douvali
    Stamatina A. Kabanarou
    Panagiotis Theodossiadis
    International Ophthalmology, 2019, 39 : 431 - 440
  • [25] Ranibizumab versus aflibercept for the treatment of vascularized pigment epithelium detachment due to age-related macular degeneration
    Rouvas, Alexandros
    Chatziralli, Irini
    Androu, Angeliki
    Mpougatsou, Panagiota
    Alonistiotis, Dimitrios
    Douvali, Maria
    Kabanarou, Stamatina A.
    Theodossiadis, Panagiotis
    INTERNATIONAL OPHTHALMOLOGY, 2019, 39 (02) : 431 - 440
  • [26] Retinal Pigment Epithelial Atrophy in Neovascular Age-Related Macular Degeneration After Ranibizumab Treatment
    Kuroda, Yoshimasa
    Yamashiro, Kenji
    Tsujikawa, Akitaka
    Ooto, Sotaro
    Tamura, Hiroshi
    Oishi, Akio
    Nakanishi, Hideo
    Miyake, Masahiro
    Yoshikawa, Munemitsu
    Yoshimura, Nagahisa
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2016, 161 : 94 - 103
  • [27] Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab
    Thi Ha Chau Tran
    Dumas, Stephane
    Coscas, Florence
    JOURNAL OF OPHTHALMOLOGY, 2017, 2017
  • [28] Surgical Drainage of a Pigment Epithelial Detachment in Neovascular Age-Related Macular Degeneration
    Ernst, Benjamin J.
    Chiranand, Paul
    Akduman, Levent
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (05): : 704 - 707
  • [29] Fluctuations in Pigment Epithelial Detachment and Retinal Fluid Using a Bimonthly Treatment Regimen with Aflibercept for Neovascular Age-Related Macular Degeneration
    Zinkernagel, Martin Sebastian
    Wolf, Sebastian
    Ebneter, Andreas
    OPHTHALMOLOGICA, 2016, 235 (01) : 42 - 48
  • [30] Non-responsiveness to intravitreal aflibercept treatment in neovascular age-related macular degeneration: implications of serous pigment epithelial detachment
    Nagai, Norihiro
    Suzuki, Misa
    Uchida, Atsuro
    Kurihara, Toshihide
    Kamoshita, Mamoru
    Minami, Sakiko
    Shinoda, Hajime
    Tsubota, Kazuo
    Ozawa, Yoko
    SCIENTIFIC REPORTS, 2016, 6
12345